Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults (Review)

Petsky, Helen L., Cates, Christopher J., Li, Albert, Kynaston, Jennifer A., Turner, Cathy and Chang, Anne B. (2009). Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults (Review)<br />. Cochrane Database of Systematic Reviews,2009(4 - Article No. CD006340).

Document type: Journal Article
Citation counts: Altmetric Score Altmetric Score is 1
Google Scholar Search Google Scholar
Attached Files (Some files may be inaccessible until you login with your CDU eSpace credentials)
Name Description MIMEType Size Downloads
Download this reading Chang_8320.pdf Published version application/pdf 511.27KB 32
Reading the attached file works best in Firefox, Chrome and IE 9 or later.

Title Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults (Review)
Author Petsky, Helen L.
Cates, Christopher J.
Li, Albert
Kynaston, Jennifer A.
Turner, Cathy
Chang, Anne B.
Journal Name Cochrane Database of Systematic Reviews
Publication Date 2009
Volume Number 2009
Issue Number 4 - Article No. CD006340
ISSN 1469-493X   (check CDU catalogue  open catalogue search in new window)
Total Pages 35
Place of Publication United Kingdom
Publisher John Wiley & Sons Ltd.
HERDC Category C2 - Journal Article - Other contributions to refereed journal (internal)
Abstract Background
The measurement of severity and control of asthma in both children and adults can be based on subjective or objective measures. It has been advocated that fractional exhaled nitric oxide (FeNO) can be used to monitor airway inflammation as it correlates with some markers of asthma. Interventions for asthma therapies have been traditionally based on symptoms and/or spirometry.

Objectives

To evaluate the efficacy of tailoring asthma interventions based on exhaled nitric oxide in comparison to clinical symptoms (with or without spirometry/peak flow) for asthma related outcomes in children and adults.

Search methods

We searched the Cochrane Airways Group Specialised Register of Trials, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and reference lists of articles. The last search was completed in February 2009.

Selection criteria

All randomised controlled comparisons of adjustment of asthma therapy based on exhaled nitric oxide compared to traditional methods (primarily clinical symptoms and spirometry/peak flow).

Data collection and analysis

Results of searches were reviewed against pre-determined criteria for inclusion. Relevant studies were independently selected in duplicate. Two authors independently assessed trial quality and extracted data. Authors were contacted for further information with response from one.

Main results

Two studies have been added for this update, which now includes six (2 adults and 4 children/adolescent) studies; these studies differed in a variety of ways including definition of asthma exacerbations, FeNO cut off levels, the way in which FeNO was used to adjust therapy and duration of study. Of 1053 participants randomised, 1010 completed the trials. In the meta-analysis, there was no significant difference between groups for the primary outcome of asthma exacerbations or for other outcomes (clinical symptoms, FeNO level and spirometry). In post-hoc analysis, a significant reduction in mean final daily dose inhaled corticosteroid per adult was found in the group where treatment was based on FeNO in comparison to clinical symptoms, (mean difference -450 mcg; 95% CI -677 to -223 mcg budesonide equivalent/day). However, the total amount of inhaled corticosteroid used in one of the adult studies was 11% greater in the FeNO arm. In contrast, in the paediatric studies, there was a significant increase in inhaled corticosteroid dose in the FeNO strategy arm (mean difference of 140 mcg; 95% CI 29 to 251, mcg budesonide equivalent/day).

Authors' conclusions

Tailoring the dose of inhaled corticosteroids based on exhaled nitric oxide in comparison to clinical symptoms was carried out in different ways in the six studies and found only modest benefit at best and potentially higher doses of inhaled corticosteroids in children. The role of utilising exhaled nitric oxide to tailor the dose of inhaled corticosteroids cannot be routinely recommended for clinical practice at this stage and remains uncertain.
DOI http://dx.doi.org/10.1002/14651858.CD006340.pub3   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)


© copyright

Every reasonable effort has been made to ensure that permission has been obtained for items included in CDU eSpace. If you believe that your rights have been infringed by this repository, please contact digitisation@cdu.edu.au.

 
Versions
Version Filter Type
Access Statistics: 71 Abstract Views, 33 File Downloads  -  Detailed Statistics
Created: Thu, 18 Feb 2010, 15:43:00 CST